Suit to Test Rights of Physicians to Receive Info on Off-Label Drug Use
WASHINGTON--The Washington Legal Foundation (WLF), a public interest group, has claimed that the FDA violated the First Amendment rights of physicians by denying them access to information about the off-label use of certain oncologic drugs.
WASHINGTON--The Washington Legal Foundation (WLF), a public interestgroup, has claimed that the FDA violated the First Amendment rightsof physicians by denying them access to information about theoff-label use of certain oncologic drugs.
WLF's suit arises from an action taken by the FDA that preventedBristol-Myers Squibb Co.from giving physicians complimentary copiesof The Chemotherapy Sourcebook, edited by Michael Perry, and chaptersfrom Cancer: Principles and Practice of Oncology, by Vincent DeVita,Samuel Hellman, and Steven Rosenberg.
Federal Judge Royce Lamberth denied the FDA's motion to dismissthe suit, thus clearing the way for a trial, which will be thefirst constitutional test of the agency's criteria to discouragewhat it views as improper promotion of drugs by means of distributionof legitimate medical educational material.
Highlighting Insights From the Marginal Zone Lymphoma Workshop
Clinicians outline the significance of the MZL Workshop, where a gathering of international experts in the field discussed updates in the disease state.
